Antiviral Activity of Peptide-Based Assemblies

ACS Appl Mater Interfaces. 2021 Oct 20;13(41):48469-48477. doi: 10.1021/acsami.1c16003. Epub 2021 Oct 8.

Abstract

The COVID-19 pandemic highlighted the importance of developing surfaces and coatings with antiviral activity. Here, we present, for the first time, peptide-based assemblies that can kill viruses. The minimal inhibitory concentration (MIC) of the assemblies is in the range tens of micrograms per milliliter. This value is 2 orders of magnitude smaller than the MIC of metal nanoparticles. When applied on a surface, by drop casting, the peptide spherical assemblies adhere to the surface and form an antiviral coating against both RNA- and DNA-based viruses including coronavirus. Our results show that the coating reduced the number of T4 bacteriophages (DNA-based virus) by 3 log, compared with an untreated surface and 6 log, when compared with a stock solution. Importantly, we showed that this coating completely inactivated canine coronavirus (RNA-based virus). This peptide-based coating can be useful wherever sterile surfaces are needed to reduce the risk of viral transmission.

Keywords: antiviral coatings; bacteriophage T4; coronavirus; peptides; self-assembly.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Bacteriophages / drug effects
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Coronavirus / drug effects
  • Coronavirus / isolation & purification
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / virology
  • Dihydroxyphenylalanine / chemistry
  • Dog Diseases / drug therapy
  • Dog Diseases / virology
  • Dogs
  • Humans
  • Metal Nanoparticles / chemistry
  • Peptides / chemistry*
  • Peptides / pharmacology
  • Peptides / therapeutic use
  • SARS-CoV-2 / isolation & purification
  • Virus Inactivation / drug effects

Substances

  • Antiviral Agents
  • Peptides
  • Dihydroxyphenylalanine